Limbach Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LMB research report →
Range $50 – $95
Price Chart
About the company
Limbach Holdings, Inc. operates as a building systems solution company in the United States. The company operates through two segments, Owner Direct Relationships and General Contractor Relationships.
- CEO
- Michael McCann
- IPO
- 2014
- Employees
- 2,100
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on LMB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $620.41M
- P/E
- 22.01
- Fwd P/E
- 13.14
- PEG
- -1.23
- P/S
- 0.93
- P/B
- 3.35
- EV/EBITDA
- 11.20
- Div Yield
- 0.00%
- Gross Margin
- 23.68%
- Op Margin
- 5.58%
- Net Margin
- 4.23%
- ROE
- 15.45%
- ROIC
- 8.54%
Latest fiscal year · YoY change
- Revenue
- $646.80M+24.7%
- Gross Profit
- $169.31M+17.4%
- Op Income
- $49.45M
- Net Income
- $48.63M+57.5%
- EPS
- $4.18+52.0%
- OCF Growth
- +24.2%
- FCF Growth
- +43.2%
- 52W High
- $114.95
- 52W Low
- $40.74
- 50D MA
- $51.38
- 200D MA
- $69.64
- Beta
- 1.36
- RSI (14)
- 49
- Avg Volume
- 283.33K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Limbach posted record Q3 revenue and EBITDA, said organic growth returned, and kept full-year guidance while pointing to a stronger setup for 2027.· November 4, 2026
- Q3 revenue, net income, and adjusted EBITDA all set records, with revenue up sharply year over year.
- Bookings were about $311 million with a 1.4x book-to-bill, marking a fourth straight quarter above 1.0x.
- Organic growth returned in owner-direct business, helped by easing timing issues and improving visibility into customer spend cycles.
- Recent acquisitions CYMCOR and 1901 expanded capabilities in data centers and electrical work, and management said they add 2027 growth avenues.
- The company kept its published 2026 ranges but said it is tracking at or near the high end of revenue and adjusted EBITDA guidance.
Third quarter revenue was a record $230.5 million, up from $184.6 million a year ago. Net income was $9.5 million, or $0.79 per diluted share, versus $8.8 million, or $0.73 per diluted share, last year. Adjusted EBITDA was a record $27.4 million versus $21.8 million. Gross margin was 23.4% and SG&A was 15% of revenue. Total organic growth was 6.6%, including 2.2% in ODR. Bookings totaled approximately $311 million, with a book-to-bill ratio of about 1.4x. For the first 9 months, revenue was $542.8 million, net income was $18.6 million, and adjusted EBITDA was $50 million. Operating cash flow was $31.2 million and company-defined free cash flow was $43.6 million, equal to 87.1% of adjusted EBITDA. Total liquidity was $164.2 million and net debt was approximately 1.6x trailing 12-month adjusted EBITDA. Management said it is tracking at or near the high end of its 2026 revenue and adjusted EBITDA ranges, which do not include CYMCOR or 1901 contributions in the August ranges.
Mike McCann framed the quarter as evidence that the company’s strategy is working: stronger bookings, a return to organic growth in owner-direct work, and acquisitions that broaden geography and technical depth. He emphasized a balance of geographic reach, vertical expertise, and an integrated operating model, with health care and industrial remaining core while technology, life sciences, and data centers expand the opportunity set. His tone was constructive and confident, but disciplined, saying the company is not raising guidance yet because it is in the middle of a significant fourth quarter and wants to finish strong.
Jayme Brooks highlighted record Q3 revenue, adjusted EBITDA, and solid cash generation, along with gross margin of 23.4% and SG&A at 15% of revenue. She said 9-month operating cash flow was $31.2 million and free cash flow was $43.6 million, with total liquidity of $164.2 million after funding CYMCOR and 1901. She also noted net debt of about 1.6x trailing adjusted EBITDA, and that the company repurchased nearly 200,000 shares for about $10 million at an average price of $51.31. On outlook, she said the company is retaining its published ranges and is near the high end, while preserving flexibility for acquisitions, working capital, and investment in the business.
Analysts focused on the recovery in ODR organic growth, the outlook for 2027, data center execution, and the mix and margin profile of GCR work. Management said the improvement stemmed from better visibility into customer spending cycles, especially in health care, plus the benefit of a national sales approach and closer customer engagement. On data centers, management said it is taking a selective, “surgical” approach, using CYMCOR and fabrication to win specific scopes with manageable risk and attractive returns. On capital allocation, Jayme said priorities remain acquisitions and being opportunistic with share repurchases, while maintaining financial flexibility.
The call showed a business that is regaining momentum: organic growth returned, bookings stayed strong, and management said customer timing issues from the first half are starting to clear. Acquisitions are already broadening the platform into higher-growth areas like data centers and electrical work, with management seeing opportunities for pull-through revenue, fabrication utilization, and margin improvement over time.
Management acknowledged that the fourth quarter is still important and said it is not raising guidance yet, which leaves execution risk on converting bookings into revenue. They also flagged that acquired businesses can pressure consolidated gross margin because of mix, and that data center work remains selective due to the need to balance opportunity, labor, and risk. The company’s confidence in 2027 is still based on current visibility, not guaranteed demand.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.4%
- Shares Outstanding
- 11.73M
- Float Shares
- 11.07M
of shares held by institutions
193 13F filers
Buy/sell ratio 7.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.01M | ▲ 26.72K |
| Vanguard Group Inc | 619.18K | ▼ 6.85K |
| Vanguard Capital Management LLC | 477.76K | ▼ 3.56K |
| Thrivent Financial For Lutherans | 356.25K | ▼ 507.96K |
| Victory Capital Management Inc | 345.41K | ▲ 345.41K |
| Marshall Wace, Llp | 338.76K | ▲ 335.26K |
| Dimensional Fund Advisors LP | 299.11K | ▲ 34.33K |
| Geode Capital Management, LLC | 290.47K | ▼ 7.58K |
| Royce & Associates LP | 281.97K | ▼ 162.35K |
| Corsair Capital Management, L.P. | 281.01K | ▼ 6.67K |
| State Street Corp | 257.01K | ▲ 3.39K |
| Citadel Advisors LLC | 256.57K | ▲ 37.64K |
Held by 220 ETFs
Biggest fund positions in LMB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 15, 26 | Sharp Jay | sell | 5,094 |
| Sep 15, 26 | Krzeminski Laurel J | buy | 500 |
| Sep 14, 26 | Gaboury David Richard | buy | 1,940 |
| Sep 15, 26 | Horowitz Joshua | buy | 662 |
| Sep 15, 26 | Horowitz Joshua | buy | 3,346 |
| Sep 11, 26 | Horowitz Joshua | buy | 2,600 |
| Sep 15, 26 | Horowitz Joshua | buy | 212 |
| Sep 11, 26 | Horowitz Joshua | buy | 1,000 |
| Jun 15, 26 | Sharp Jay | sell | 788 |
| Jun 15, 26 | Sharp Jay | sell | 1,862 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LMB coverage
Recent articles, reports, and earnings notes.
No research on LMB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LMB report →Limbach Holdings: Stock Recovery Catalyzed By Q3 2026 Results
seekingalpha.com · Nov 13
Limbach Holdings, Inc. $LMB Position Reduced by CenterBook Partners LP
defenseworld.net · Nov 10
Wall Street Analysts See a 37.61% Upside in Limbach (LMB): Can the Stock Really Move This High?
zacks.com · Nov 6
Despite Fast-paced Momentum, Limbach (LMB) Is Still a Bargain Stock
zacks.com · Nov 6
Limbach Q3 Earnings Call Highlights
marketbeat.com · Nov 4
Limbach Holdings, Inc. (LMB) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 4
Why Limbach Holdings Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
benzinga.com · Nov 4
Limbach (LMB) Tops Q3 Earnings and Revenue Estimates
zacks.com · Nov 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.